American Vanguard Co. (NYSE:AVD – Get Free Report) Director Keith M. Rosenbloom purchased 25,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were bought at an average price of $5.94 per share, for a total transaction of $148,500.00. Following the completion of the transaction, the director now directly owns 1,193,682 shares in the company, valued at approximately $7,090,471.08. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
American Vanguard Trading Up 0.9 %
AVD opened at $6.13 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.08 and a current ratio of 2.22. American Vanguard Co. has a twelve month low of $4.95 and a twelve month high of $14.28. The firm’s fifty day moving average is $7.56 and its two-hundred day moving average is $9.56. The firm has a market cap of $171.41 million, a PE ratio of 23.56 and a beta of 0.91.
American Vanguard (NYSE:AVD – Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The basic materials company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.08). American Vanguard had a negative net margin of 0.60% and a positive return on equity of 1.85%. The business had revenue of $128.21 million during the quarter, compared to analyst estimates of $134.20 million. Equities research analysts anticipate that American Vanguard Co. will post 0.02 EPS for the current year.
Hedge Funds Weigh In On American Vanguard
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the company. Lake Street Capital initiated coverage on American Vanguard in a report on Monday, July 22nd. They issued a “buy” rating and a $14.00 target price for the company. StockNews.com downgraded shares of American Vanguard from a “hold” rating to a “sell” rating in a research report on Tuesday, August 13th. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $16.67.
View Our Latest Analysis on American Vanguard
About American Vanguard
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Featured Articles
- Five stocks we like better than American Vanguard
- Where Do I Find 52-Week Highs and Lows?
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- The Role Economic Reports Play in a Successful Investment Strategy
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- The 3 Best Retail Stocks to Shop for in August
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.